Side effects associated with current and prospective antimigraine pharmacotherapies

Gonzalez-Hernandez, A; Marichal-Cancino, BA; MaassenVanDenBrink, A; Villalon, CM

Villalon, CM (reprint author), Cinvestav Coapa, Dept Farmacobiol, Mexico City, DF, Mexico.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018; 14 (1): 25

Abstract

Introduction: Migraine is a neurovascular disorder. Current acute specific antimigraine pharmacotherapies target trigeminovascular 5-HT1B/1D, 5-HT1F a......

Full Text Link